New axis in hypertension

U.S. and European researchers have found that deleting the prostaglandin

F receptor can lower both blood pressure and atherosclerotic plaque formation in mice.¹ Now that the receptor has been shown to be involved in the renin-angiotensin system, it offers a new way to attack a pathway that has already yielded multiple marketed drugs...